Accessibility Menu

Fresenius Medical Care(FRA) FMEA

Market Cap€10.64BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€19.50
-1.52%
-0.30Today

Fresenius Medical Care Financials at a Glance

Market Cap

€10.64BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€19.43K

Net Income (TTM)

€1.19K

EPS (TTM)

€1.66

P/E Ratio

12.03

Dividend

€0.75

Beta (Volatility)

0.07 (Low)

Price

€19.50

Volume

0

Open

€19.50

Previous Close

€19.50

Daily Range

€19.50 - €19.50

52-Week Range

€17.50 - €23.60

Estimated Earnings Date

N/A

FMEA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fresenius Medical Care

Fresenius Medical Care AG & Co. KgaA engages in the provision of products and services for individuals with renal diseases of which regularly undergo dialysis treatment. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the healthcare services business. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

107,226

CEO

Helen Giza, MBA

Website

www.freseniusmedicalcare.com/de

FMEA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

7.26%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

8.31%

Dividend Yield

3.72%

Payout Ratio

N/A

Stock Overview

Market Cap

€10.64BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

532.22M

Volume

0

Avg. Volume

19.985

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Fresenius Medical Care Performance Analysis

Fresenius Medical Care annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 19,395,319,00010.1%
20232023-12-31EUR 19,454,117,0000.3%
20242024-12-31EUR 19,337,749,000-0.6%
20252025-12-31EUR 19,636,867,0001.5%
Fresenius Medical Care annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.15-30.6%
20232023-12-31EUR 0.85-25.9%
20242024-12-31EUR 0.927.8%
20252025-12-31EUR 1.6883.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€4.86K

+1.0%

Gross Profit

€1.31K

+1.1%

Gross Margin

26.95%

+1.1%

Market Cap

€10.64BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.09

+0.7%

Employees

107,226

+1.0%

Net Income

€293.17

+1.1%

EBITDA

€897.45

+1.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€12.02K

-5.6%

Total Debt

€10.96K

+1.0%

Accounts Receivable

€3.35K

+1.0%

Inventory

€2.33K

+1.2%

Long Term Debt

€8.64K

+0.9%

Short Term Debt

€2.33K

+1.5%

Return on Assets

3.00%

+1.5%

Return on Invested Capital

3.11%

+0.9%

Free Cash Flow

€623.60

+1.1%

Operating Cash Flow

€866.42

+1.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About FMEA

What is the current price of Fresenius Medical Care?

Fresenius Medical Care is trading at €19.50 per share.

What is the 52-week range for Fresenius Medical Care?

Over the past 52 weeks, Fresenius Medical Care has traded between €17.50 and €23.60.

How much debt does Fresenius Medical Care have?

As of the most recent reporting period, Fresenius Medical Care reported total debt of €10.96B.

How much cash does Fresenius Medical Care have on hand?

Fresenius Medical Care reported €1.06B in cash and cash equivalents in its most recent financial results.

What is Fresenius Medical Care’s dividend yield?

Fresenius Medical Care currently has a dividend yield of 3.72%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services